SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)
RIGL 35.20-2.6%Nov 7 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (26)12/12/2001 3:10:43 PM
From: Jim Oravetz  Read Replies (1) of 566
 
Rigel Pharmaceutical Files $50M Mixed Securities Shelf

WASHINGTON -- Rigel Pharmaceuticals Inc. (RIGL) filed with the Securities and Exchange Commission Tuesday to offer $50 million in mixed securities from time to time.

According to the filing, Rigel Pharmaceuticals plans to use proceeds from the sale of the common stock, preferred stock, debt securities and warrants for research and development.

No underwriters were named in the filing, and the company said it would provide specifics on the securities through prospectus supplements.

Rigel Pharmaceuticals, of South San Francisco, develops drug candidates with rapid drug target identification and validation technology.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext